Article 4 consultation — nicotinamide mononucleotide
Novel Food conclusion for NMN at 95–99% purity produced enzymatically


EU + POLAND EVIDENCE PROFILE
A defined molecule with a published EU Novel Food conclusion and active application history — not a shortcut to market access.
IDENTITY BEFORE STATUS
CLAIMS
A Novel Food application is not an authorisation. Confirm the current Union list before any market-access conclusion.
RESTRICTIONS
Treat the cited 95–99% NMN as Novel Food unless a matching Union-list authorisation and conditions are evidenced.
Match identity, purity, production process, intended use, daily intake and target population to any relied-on authorisation.
Do not present a pending or published application summary as permission to sell.
POLISH NOTES
EU Novel Food authorisation is a gate before a Polish supplement notification can resolve product placement.
Keep anti-ageing and disease-adjacent presentation out of the ingredient identity analysis; review it separately as marketing content.
PRIMARY SOURCES
Novel Food conclusion for NMN at 95–99% purity produced enzymatically
Application history; not evidence of authorisation
Market-authorisation verification gate